Startup developing HPV vaccine raises $2.75 million
PathoVax plans to initiate Phase 1 clinical trials for its HPV vaccine in the first half of 2020.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Morgan Eichensehr Source Type: news